REPLACE – Seven Steps to Remember During A Massive Blood Transfusion

What Do I Need To Remember During A Massive Blood Transfusion?

At first thought, this seems like an obvious answer: give blood! However, the amount of blood that a person receives during a massive blood transfusion causes a set of complications within itself that need to be addressed concurrently. To remember the principles involved with managing a patient requiring a massive blood transfusion, remember the acronym REPLACE:

• Replace volume
• Exsanguination cessation
• Permissive hypotension
• Low temperature management
• Acidosis management
• Coagulopathy management
• Electrolyte management

Note: A massive blood transfusion can be defined as follows:

• The transfusion of an adult’s blood volume within 24 hours – this can also be defined as having to administer more than 10 units of packed red blood cells in 24 hours, or the anticipated need to do so.
• The transfusion of half an adult’s blood volume in 4 hours – this can also be defined as having to administer more than 4 units of packed red blood cells in 4 hours, or the anticipated need to do so.

(The average blood volume of an adult is approximately 70 mL/kg of ideal body weight.)

R.E.P.L.A.C.E.

Replacement of intravascular volume loss

The problem with bleeding profusely is that we lose intravascular volume and circulating haemoglobin, resulting in decreased perfusion of vital organs eventually leading to what we know as hypovolaemic shock. The general rule of thumb is that we replace the intravascular volume with what we are losing. So in a bleeding patient, we should replace with blood. A little bit of crystalloid filling can be considered to dilute the blood and help circulate it around the body, but a 1:1 ratio of blood to crystalloid is no longer advocated due to increased adverse outcomes.

Exsanguination cessation

Attempts to replace the blood that is being lost are futile if the bleeding is not stopped. If the bleeding is external, try to control of it by compressing the bleeding site, applying a tourniquet above the bleeding extremity or packing the bleeding wound. If the bleeding is internal, there needs to be an urgent surgical intervention to find the source and control it.

Permissive hypotension

Adopt the Goldilocks principle here; not too much, not too little…just right! Permissive hypotension of 80-100 mmHg systolic is usually recommended until the bleeding has stopped, as adding more force behind the bleed is only going to worsen it.

Low body temperature management

Blood comes straight from the fridge at a temperature of 8 degrees celsius, and cold blood does not clot! Hypothermic people also have a slower heart rate, decreased myocardial contractility and impaired uptake of oxygen by the cells; leading to worsening shock. It is easier to keep a patient warm than trying to warm them up. Use a blood warmer to administer the blood where possible and remember to put an active warming blanket on the person, aiming for a temperature of more than 35 degrees celsius.

Acidosis management

Each unit of blood contains approximately 15 mmol of hydrogen ions. As the kidneys are only able to eliminate approximately 1 mmol/kg of hydrogen ions a day, acidosis can occur with massive blood transfusions as the kidneys are unable to keep up with the buffering and removal of that many hydrogen ions. Furthermore, each unit of blood has a base deficit of 20 mmol/L to 40 mmol/L depending on the age of the bag, with a base deficit reducing the ability of the body to buffer a worsening acidosis. The metabolic acidosis will eventually rectify itself once the bleeding has been stopped. Prophylactic administration of intravenous bicarbonate should only be considered if the pH is less than 7.2.

Coagulopathy management

There are various blood products and adjuncts that can be administered to help slow the bleeding including:

• Fresh Frozen Plasma (FFP) that contains all the coagulation factors in normal concentrations and promotes coagulation of blood along the intrinsic, extrinsic and common pathways – give 15 mL/kg if INR is more than 1.5
• Platelets that help to form a stabilised clot by binding with fibrin fibres – give one unit if platelets are less than 50,000 mCL
• Cryoprecipitate that contains mostly fibrinogen, factor 8, factor 13 and von Willebrand factor – give 3-4 grams if the fibrinogen is less than 1.0 g/L
• Desmopressin (DDAVP) which increases the amount of von Willebrand factor circulating within the bloodstream, thereby facilitating platelets binding to each other and the transport of factor 8 around the body
• Tranexamic acid (TXA) which is an antifibrinolytic that works to counteract the degrading effects that plasmin has on fibrin, thereby preserving stabilised fibrin to participate in the clotting process for longer
• Protamine which helps reverse the effects of heparin, if the bleeding is thought to be a result of a heparin induced coagulopathy,
• Vitamin K which helps activate factors 2, 7, 9 and 10, if the bleeding is thought to be a result of a warfarin induced coagulopathy

Electrolyte derangement management

Each unit of blood contains citrate that works to prevent blood clotting by binding to ionised calcium, impeding the clotting cascade significantly. The liver converts citrate to bicarbonate thereby releasing calcium ions to facilitate the clotting ability of the blood, but a massive blood transfusion overwhelms this process. For this reason, calcium needs to be replaced to maintain an ionised calcium level of more than 1.1 mmol/L. Each unit of blood also leaks potassium proportionately throughout their storage life, with more circulating potassium in an older bag of blood. Hyperkalaemia can be minimised by utilising blood bags that are less than 7 days old in massive blood transfusions. In the event that this is not feasible, an insulin and glucose infusion may need to be commenced to lower potassium levels within the blood. Insulin works as a carrier molecule to move potassium from the extracellular space into the intracellular space. It also reduces the glucose levels within the body, which is why a concurrent glucose infusion is necessary to avoid hypoglycaemia.

---

 

 

[show_more more=”Show References” less=”Hide References” align=”center” color=”#808080″]

References

• Hess, JR 2015, Massive blood transfusion, viewed 31 May 2016, http://www.uptodate.com/contents/massive-blood-transfusion
• Maxwell, MJ & Wilson, MJA 2006, ‘Complications of blood transfusion,’ Continuing education in anaesthesia, critical care and pain, 6(6), pp. 225-229. doi: 10.1093/bjaceaccp/mkl053
• National Blood Authority Australia 2011, Patient blood management guidelines: Critical bleeding massive transfusion, viewed 31 May 2016, https://www.blood.gov.au/pubs/pbm/module1/contents.html

[/show_more]